Lymphoma

The Pharmacy Times® Lymphoma Resource Center is a comprehensive resource for clinical news and expert insights on treatments for lymphoma, a cancer that begins in cells of the lymph system. Common treatments for lymphoma may involve chemotherapy, medication, radiation therapy, and stem cell transplant.

Latest News

EHA 2025: Golcadomide Shows Deep Responses in High-Risk Follicular Lymphoma
EHA 2025: Golcadomide Shows Deep Responses in High-Risk Follicular Lymphoma

July 29th 2025

Julio C. Chavez, MD, MS, discusses the distinct pharmacologic profile, clinical activity, and outpatient potential of golcadomide plus rituximab in relapsed/refractory follicular lymphoma, highlighting its selective cereblon modulation, fixed-duration dosing, and promising efficacy in heavily pretreated patients.

EHA 2025: GOLCA Plus Rituximab Shows Promise in R/R DLBCL
EHA 2025: GOLCA Plus Rituximab Shows Promise in R/R DLBCL

July 28th 2025

EHA 2025: No Added Toxicity Observed With Bleximenib Plus Venetoclax and Azacitidine in AML
EHA 2025: No Added Toxicity Observed With Bleximenib Plus Venetoclax and Azacitidine in AML

July 22nd 2025

EHA 2025: BMS-986458 Shows Clinical Promise in FL and DLBCL
EHA 2025: BMS-986458 Shows Clinical Promise in FL and DLBCL

July 21st 2025

Diffuse large B cell lymphoma (DLBCL) -- Image credit: SuriyaPhoto | stock.adobe.com
FDA Issues Complete Response Letter for Glofit-GemOx in R/R DLBCL

July 18th 2025

Video Interviews
Podcasts
Latest CME Events & Activities

More News